APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-steroidal Anti-inflammatory Drugs (NSAID)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Forecast 2026-2032

Report ID 174017750226 December 2025197 pages

Choose your research edition.

Industry ResearchNon-steroidal Anti-inflammatory Drugs (NSAID) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Non-steroidal Anti-inflammatory Drugs (NSAID) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Merck Animal Health, Bayer, Zoetis, St. Joseph, Merial, Generic, Elanco, Ecotrin and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non-steroidal Anti-inflammatory Drugs (NSAID), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-steroidal Anti-inflammatory Drugs (NSAID), also provides the sales of main regions and countries. Of the upcoming market potential for Non-steroidal Anti-inflammatory Drugs (NSAID), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-steroidal Anti-inflammatory Drugs (NSAID) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-steroidal Anti-inflammatory Drugs (NSAID) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non-steroidal Anti-inflammatory Drugs (NSAID) sales, projected growth trends, production technology, application and end-user industry.

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Company

Merck Animal Health

Bayer

Zoetis

St. Joseph

Merial

Generic

Elanco

Ecotrin

Boehringer Ingelheim

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type

Propionic acid derivatives

Sulfonanilides

Anthranilic acid derivatives (Fenamates)

Salicylates

Enolic acid (Oxicam) derivatives

Selective COX-2 inhibitors (Coxibs)

Acetic acid derivatives

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application

Human

Animals

Others

Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-steroidal Anti-inflammatory Drugs (NSAID) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-steroidal Anti-inflammatory Drugs (NSAID).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-steroidal Anti-inflammatory Drugs (NSAID) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Propionic acid derivatives Major Manufacturers Table 3. Sulfonanilides Major Manufacturers Table 4. Anthranilic acid derivatives (Fenamates) Major Manufacturers Table 5. Salicylates Major Manufacturers Table 6. Enolic acid (Oxicam) derivatives Major Manufacturers Table 7. Selective COX-2 inhibitors (Coxibs) Major Manufacturers Table 8. Acetic acid derivatives Major Manufacturers Table 9. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Human Major Manufacturers Table 11. Animals Major Manufacturers Table 12. Others Major Manufacturers Table 13. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends Table 14. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Drivers Table 15. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Opportunities and Challenges Table 16. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Restraints Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2021-2026) Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2027-2032) Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021-2026) & (W Units) Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2027-2032) & (W Units) Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2021-2026) Table 26. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2027-2032) Table 27. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2021-2026) Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers, Product Type & Application Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2021-2026) Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2027-2032) Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (W Units) Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2027-2032) & (W Units) Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2021-2026) Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2027-2032) Table 48. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2026) & (US$/Unit) Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2027-2032) & (US$/Unit) Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2021-2026) Table 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2027-2032) Table 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (W Units) Table 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2027-2032) & (W Units) Table 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2021-2026) Table 59. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2027-2032) Table 60. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2026) & (US$/Unit) Table 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2027-2032) & (US$/Unit) Table 62. Merck Animal Health Company Information Table 63. Merck Animal Health Business Overview Table 64. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 66. Merck Animal Health Recent Development Table 67. Bayer Company Information Table 68. Bayer Business Overview Table 69. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 71. Bayer Recent Development Table 72. Zoetis Company Information Table 73. Zoetis Business Overview Table 74. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 76. Zoetis Recent Development Table 77. St. Joseph Company Information Table 78. St. Joseph Business Overview Table 79. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 81. St. Joseph Recent Development Table 82. Merial Company Information Table 83. Merial Business Overview Table 84. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 86. Merial Recent Development Table 87. Generic Company Information Table 88. Generic Business Overview Table 89. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 91. Generic Recent Development Table 92. Elanco Company Information Table 93. Elanco Business Overview Table 94. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 96. Elanco Recent Development Table 97. Ecotrin Company Information Table 98. Ecotrin Business Overview Table 99. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 101. Ecotrin Recent Development Table 102. Boehringer Ingelheim Company Information Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio Table 106. Boehringer Ingelheim Recent Development Table 107. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (W Units) Table 110. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2027-2032) & (W Units) Table 111. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (W Units) Table 116. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2027-2032) & (W Units) Table 117. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 123. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 124. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 125. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 128. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 129. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 130. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (W Units) Table 133. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2027-2032) & (W Units) Table 134. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (W Units) Table 139. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2027-2032) & (W Units) Table 140. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 146. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 147. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 148. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 151. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 152. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 153. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 154. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 155. Spain Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 157. Switzerland Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 158. Sweden Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 159. Poland Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 160. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (US$ Million) Table 161. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2027-2032) & (US$ Million) Table 162. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (W Units) Table 163. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2027-2032) & (W Units) Table 164. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2021-2026) & (US$/Unit) Table 165. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2027-2032) & (US$/Unit) Table 166. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (US$ Million) Table 167. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2027-2032) & (US$ Million) Table 168. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (W Units) Table 169. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2027-2032) & (W Units) Table 170. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2021-2026) & (US$/Unit) Table 171. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (W Units) Table 175. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2027-2032) & (W Units) Table 176. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (W Units) Table 181. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2027-2032) & (W Units) Table 182. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 188. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 189. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 190. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 193. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 194. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 195. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 196. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2026) & (W Units) Table 201. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2027-2032) & (W Units) Table 202. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2021-2026) & (US$/Unit) Table 203. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Type (2027-2032) & (US$/Unit) Table 204. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2026) & (W Units) Table 207. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2027-2032) & (W Units) Table 208. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2021-2026) & (US$/Unit) Table 209. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Application (2027-2032) & (US$/Unit) Table 210. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 214. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021-2026) & (W Units) Table 215. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2027-2032) & (W Units) Table 216. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2021-2026) & (US$/Unit) Table 217. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 219. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 220. Chile Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 221. Colombia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 222. Peru Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 224. Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 225. UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 226. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 227. Iran Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 228. Egypt Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List Table 232. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Image Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Propionic acid derivatives Image Figure 5. Sulfonanilides Image Figure 6. Anthranilic acid derivatives (Fenamates) Image Figure 7. Salicylates Image Figure 8. Enolic acid (Oxicam) derivatives Image Figure 9. Selective COX-2 inhibitors (Coxibs) Image Figure 10. Acetic acid derivatives Image Figure 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Share 2021 VS 2025 VS 2032 Figure 13. Human Image Figure 14. Animals Image Figure 15. Others Image Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2021-2032) & (US$ Million) Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2021-2032) Figure 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2021-2032) & (W Units) Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2021-2032) & (W Units) Figure 25. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2021-2032) & (W Units) Figure 26. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2021-2032) & (W Units) Figure 27. Asia (Excluding China) Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2021-2032) & (W Units) Figure 28. South America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2021-2032) & (W Units) Figure 29. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2021-2032) Figure 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2021-2032) Figure 38. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2021-2032) Figure 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2021-2032) Figure 44. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2021-2032) Figure 45. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2021-2032) Figure 46. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2021-2032) Figure 47. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2021-2032) Figure 48. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2021-2032) Figure 49. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2021-2032) Figure 50. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2021-2032) Figure 51. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2021-2032) Figure 52. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2021-2032) Figure 53. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2021-2032) Figure 54. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2021-2032) Figure 55. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2021-2032) Figure 56. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2021-2032) Figure 57. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2021-2032) Figure 58. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2021-2032) Figure 59. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2021-2032) Figure 60. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2021-2032) Figure 61. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2021-2032) Figure 62. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2021-2032) Figure 63. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2021-2032) Figure 64. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2021-2032) Figure 65. Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2021-2032) Figure 66. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2021-2032) Figure 67. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2021-2032) Figure 68. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2021-2032) Figure 69. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2021-2032) Figure 70. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2021-2032) Figure 71. SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2021-2032) Figure 72. Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Propionic acid derivatives
  • Sulfonanilides
  • Anthranilic acid derivatives (Fenamates)
  • Salicylates
  • Enolic acid (Oxicam) derivatives
  • Selective COX-2 inhibitors (Coxibs)
  • Acetic acid derivatives
Applications
  • Human
  • Animals
  • Others
Companies covered
  • Merck Animal Health
  • Bayer
  • Zoetis
  • St. Joseph
  • Merial
  • Generic
  • Elanco
  • Ecotrin
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Type
  3. 1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Propionic acid derivatives
  5. 1.2.3 Sulfonanilides
  6. 1.2.4 Anthranilic acid derivatives (Fenamates)
  7. 1.2.5 Salicylates
  8. 1.2.6 Enolic acid (Oxicam) derivatives
  9. 1.2.7 Selective COX-2 inhibitors (Coxibs)
  10. 1.2.8 Acetic acid derivatives
  11. 1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Application
  12. 1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Human
  14. 1.3.3 Animals
  15. 1.3.4 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Dynamics
  1. 2.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
  2. 2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Drivers
  3. 2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Opportunities and Challenges
  4. 2.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
  3. 3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2021-2026)
  5. 3.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2027-2032)
  6. 3.2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
  9. 3.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2021-2026)
  11. 3.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2027-2032)
  12. 3.4.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers
  2. 4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers
  6. 4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers, Product Type & Application
  13. 4.7 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market CR5 and HHI
  16. 4.8.2 2025 Non-steroidal Anti-inflammatory Drugs (NSAID) Tier 1, Tier 2, and Tier 3
5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Type
  1. 5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type
  2. 5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type
  6. 5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type
6 Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Application
  1. 6.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application
  2. 6.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application
  6. 6.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application
7 Company Profiles
  1. 7.1 Merck Animal Health
  2. 7.1.1 Merck Animal Health Company Information
  3. 7.1.2 Merck Animal Health Business Overview
  4. 7.1.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  6. 7.1.5 Merck Animal Health Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Zoetis
  14. 7.3.1 Zoetis Company Information
  15. 7.3.2 Zoetis Business Overview
  16. 7.3.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  18. 7.3.5 Zoetis Recent Developments
  19. 7.4 St. Joseph
  20. 7.4.1 St. Joseph Company Information
  21. 7.4.2 St. Joseph Business Overview
  22. 7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  24. 7.4.5 St. Joseph Recent Developments
  25. 7.5 Merial
  26. 7.5.1 Merial Company Information
  27. 7.5.2 Merial Business Overview
  28. 7.5.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  30. 7.5.5 Merial Recent Developments
  31. 7.6 Generic
  32. 7.6.1 Generic Company Information
  33. 7.6.2 Generic Business Overview
  34. 7.6.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  36. 7.6.5 Generic Recent Developments
  37. 7.7 Elanco
  38. 7.7.1 Elanco Company Information
  39. 7.7.2 Elanco Business Overview
  40. 7.7.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  42. 7.7.5 Elanco Recent Developments
  43. 7.8 Ecotrin
  44. 7.8.1 Ecotrin Company Information
  45. 7.8.2 Ecotrin Business Overview
  46. 7.8.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  48. 7.8.5 Ecotrin Recent Developments
  49. 7.9 Boehringer Ingelheim
  50. 7.9.1 Boehringer Ingelheim Company Information
  51. 7.9.2 Boehringer Ingelheim Business Overview
  52. 7.9.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
  54. 7.9.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
  2. 8.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032)
  3. 8.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032)
  4. 8.1.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2032)
  5. 8.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
  6. 8.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032)
  7. 8.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032)
  8. 8.2.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2032)
  9. 8.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
  10. 8.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
  2. 9.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032)
  4. 9.1.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2032)
  5. 9.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
  6. 9.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032)
  8. 9.2.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2032)
  9. 9.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
  10. 9.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
  2. 10.1.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032)
  3. 10.1.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032)
  4. 10.1.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2032)
  5. 10.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
  6. 10.2.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032)
  7. 10.2.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032)
  8. 10.2.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
  2. 11.1.1 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032)
  4. 11.1.3 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2032)
  5. 11.2 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
  6. 11.2.1 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032)
  8. 11.2.3 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2032)
  9. 11.3 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
  10. 11.3.1 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
  2. 12.1.1 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2021-2032)
  5. 12.2 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
  6. 12.2.1 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2021-2032)
  9. 12.3 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
  10. 12.3.1 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain Analysis
  2. 13.1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
  6. 13.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
  9. 13.2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst